What is the prevalence of Chediak Higashi Syndrome?

Chediak-Higashi syndrome is an ultra-rare genetic disorder with fewer than 500 cases documented in medical literature worldwide, making exact prevalence statistics difficult to establish. The condition is inherited in an autosomal recessive pattern, and because of its clinical severity and frequent underdiagnosis, the true global prevalence remains unknown.

How rare is Chediak-Higashi syndrome?

Chediak-Higashi syndrome is classified as an ultra-rare disease. Due to its extreme rarity and the complexity of its presentation—which often includes immune deficiency, albinism, and neurological involvement—many individuals may go undiagnosed or be misdiagnosed until they experience a severe "accelerated phase" of the disease. While global incidence is not precisely tracked, it is estimated that fewer than 500 cases have been reported in medical literature since the condition was first described.

Are there demographic or genetic patterns in Chediak-Higashi syndrome?

Chediak-Higashi syndrome affects males and females equally, as the causative mutation occurs on the LYST gene located on chromosome 1. Because the condition is autosomal recessive, both parents must be carriers for a child to be affected. While no specific ethnic group is exclusively predisposed to Chediak-Higashi syndrome, cases have been reported globally. The onset is typically pediatric, often presenting in infancy with distinctive symptoms such as partial oculocutaneous albinism and recurrent infections.

Why is prevalence data for Chediak-Higashi syndrome limited?

Accurate epidemiological data for Chediak-Higashi syndrome is hindered by several factors:

• Underdiagnosis: Mild or atypical presentations may not be recognized by clinicians unfamiliar with the condition.


• Misdiagnosis: Symptoms can overlap with other primary immunodeficiencies or hemophagocytic lymphohistiocytosis (HLH).


• Reporting Bias: Only the most severe or academically interesting cases are historically documented in medical literature.

At DiseaseMaps.org, we have 3 members currently sharing their lived experience with Chediak-Higashi syndrome, providing a vital, real-world perspective that complements clinical data.

Next steps

• Consult with a clinical geneticist or immunologist to confirm a diagnosis through LYST gene mutation analysis.


• Connect with the DiseaseMaps.org community to share experiences and find support from others navigating this rare diagnosis.


• Engage with organizations like the Histiocytosis Association to stay updated on specialized care and clinical research.

Medical disclaimer: This information is for educational purposes only and does not constitute professional medical advice, diagnosis, or treatment.

References

• NIH Genetic and Rare Diseases Information Center (GARD): Chediak-Higashi syndrome.


• Orphanet: Rare disease database entry for Chediak-Higashi syndrome (ORPHA:167).


• Online Mendelian Inheritance in Man (OMIM): Entry #214500 (Chediak-Higashi syndrome).